NYSE:PTN

Palatin Technologies Stock Predictions

> Biotechnology

Buy PTN

*Your capital is at risk

$10.60

-0.610 (-5.44%)

At Close: Jun 24, 2026

Currently predicting for Thu, 25 Jun 2026

PTN Live board

Community Bull/Bear

Target Next close

Join the PTN prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

PTN Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For PTN

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

PTN Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT PALATIN TECHNOLOGIES INC

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
NESR $25.06	0.439%	Jun 22
IDYA $28.98	25.19%	Jun 12
PHM $118.49	14.53%	Jun 10
DHI $146.71	13.50%	Jun 10
EAT $140.46	20.94%	Jun 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by